🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524999-37-00
Authorised Phase I

A study comparing different dosage forms of midazolam and how they are taken up in the body.

2025-524999-37-00 · tracked via the Priya Life Science EU tracker
Sponsor
MIDAS Pharma GmbH
Sponsor type
Pharmaceutical company
Therapeutic area
Anesthesia and Analgesia
Decision date
26/05/2026
Enrollment target
16
Sites
Czechia

Condition studied

Bioavailability Study under Fasting Conditions

Eligibility

Age group
18-64 years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524999-37-00 on CTIS ↗ ← All trials in the EU